PHS
KRTX
PFM Health Sciences’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-130,293
| Closed | -$41.2M | – | 87 |
|
2023
Q4 | $41.2M | Sell |
130,293
-7,916
| -6% | -$2.51M | 2.47% | 12 |
|
2023
Q3 | $23.4M | Hold |
138,209
| – | – | 1.1% | 39 |
|
2023
Q2 | $30M | Hold |
138,209
| – | – | 1.16% | 38 |
|
2023
Q1 | $25.1M | Buy |
138,209
+7,916
| +6% | +$1.44M | 1.11% | 36 |
|
2022
Q4 | $25.6M | Hold |
130,293
| – | – | 0.92% | 38 |
|
2022
Q3 | $29.3M | Hold |
130,293
| – | – | 1.06% | 42 |
|
2022
Q2 | $16.5M | Sell |
130,293
-76,823
| -37% | -$9.72M | 0.63% | 50 |
|
2022
Q1 | $26.3M | Buy |
207,116
+30,025
| +17% | +$3.81M | 0.98% | 41 |
|
2021
Q4 | $23.2M | Hold |
177,091
| – | – | 0.79% | 44 |
|
2021
Q3 | $21.7M | Sell |
177,091
-16,295
| -8% | -$1.99M | 0.64% | 45 |
|
2021
Q2 | $22M | Buy |
193,386
+14,540
| +8% | +$1.66M | 0.69% | 46 |
|
2021
Q1 | $21.5M | Buy |
+178,846
| New | +$21.5M | 0.66% | 46 |
|
2020
Q4 | – | Sell |
-137,960
| Closed | -$10.7M | – | 96 |
|
2020
Q3 | $10.7M | Sell |
137,960
-214,585
| -61% | -$16.6M | 0.49% | 52 |
|
2020
Q2 | $39.3M | Sell |
352,545
-146,965
| -29% | -$16.4M | 2.04% | 14 |
|
2020
Q1 | $36M | Sell |
499,510
-103,041
| -17% | -$7.42M | 2.95% | 10 |
|
2019
Q4 | $45.4M | Buy |
602,551
+191,908
| +47% | +$14.5M | 2.16% | 16 |
|
2019
Q3 | $6.7M | Sell |
410,643
-362,388
| -47% | -$5.91M | 0.2% | 60 |
|
2019
Q2 | $14.2M | Buy |
+773,031
| New | +$14.2M | 0.27% | 67 |
|